arrow
T

Thomas Skripuletz

Hannover Medical School
H指数:43
被引数:8,268

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Convergence of Cerebrospinal Fluid Neuronal Biomarker Burden and MRI Lesion Pattern and Its Association With Short‐Term Outcome in Neuroinfectious Diseases

脑脊液神经元生物标志物负荷与<scp>MRI</scp>病灶模式的收敛及其与神经感染性疾病短期预后的关联

2026-11-020
OAAI
CSF cytology: core principles, diagnostic pitfalls and emerging digital tools including artificial intelligence and telecytology

脑脊液细胞学:核心原则、诊断陷阱及新兴数字工具(包括人工智能和远程细胞学)

2026-10-300
OAAI
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany – expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN)

德国遗传性甲状腺素转运蛋白淀粉样变性伴多发性神经病变的疾病修饰治疗——德国淀粉样变性学会(DGAK)和德国神经病学学会(DGN)的专家共识

2026-08-110
OAAI
Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

不同评定者间的变异是否影响根据多发性硬化症诊断标准进行的分类?

2026-01-230
OAAI
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study

C反应蛋白升高作为免疫检查点抑制剂治疗中神经不良反应的潜在生物标志物:一项前瞻性队列研究

2026-01-010
PRE
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy

氯达拉滨片在多发性硬化治疗中实现无治疗缓解是否是一个现实的目标?关于氯达拉滨片作用机制及免疫重建的临床意义的新见解

2025-11-270
OAAI
Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study

从静脉免疫球蛋白转换为皮下免疫球蛋白在CIDP和MMN中的应用:一项观察性研究12个月的结果

2025-11-180
OAAI
Serum and cerebrospinal kappa free light chains in psychiatric syndromes with neuronal and paraneoplastic autoantibodies

精神神经综合征中伴有神经元及副肿瘤自身抗体的血清和脑脊液游离κ轻链

2025-09-300
OAAI
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab

经奥瑞利珠单抗清除CD20后,血清中κ游离轻链浓度降低。

2025-08-220
OAAI
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors

低甘油三酯水平与接受免疫检查点抑制剂治疗的患者发生免疫相关不良事件的风险增加相关。

2025-08-160
OAAI
Correction: Neural autoantibodies in psychiatric disorders are associated with antibodies against viral pathogens: a retrospective study of 619 patients

更正:精神障碍中的神经自身抗体与抗病毒病原体抗体相关:一项619例患者的回顾性研究

2025-07-210
OA